Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02432352
Other study ID # K01MH096646
Secondary ID
Status Completed
Phase Phase 1
First received April 19, 2015
Last updated July 31, 2017
Start date May 2015
Est. completion date July 31, 2017

Study information

Verified date July 2017
Source Brown University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the feasibility and acceptability of a family-based preventive intervention designed to reduce sexual risk behaviors and depressive symptoms among South African adolescents and their parents/guardians/caregivers.


Description:

The Our Family Our Future Program is a preventive intervention program designed to prevent or reduce adolescent sexual risk behavior and to increase mental health resilience against depression onset among adolescents (13-15 years of age). The intervention takes a family approach and addresses HIV risk and depression in an integrated model. HIV and depression are the leading causes of global burden of disease in low and middle income countries. The intervention is being tested in South Africa, the country confronting the largest HIV epidemic in the world and because preliminary studies with South African families identified poor mental health and sexual risk behavior as priority areas for preventive intervention development and testing.

This study is a randomized pilot design, where 152 adolescents and parents will be randomly assigned to an intervention condition or a standard usual care condition and then offered the experimental intervention as on a wait-list. Families will be recruited and screened for eligibility based on systematic house-to-house recruitment in the community. Eligibility is based on dyadic eligibility and includes age criteria, consistent presence in the household, depressive symptoms that fall below clinically significant threshold criteria, and ability to provide informed consent and assent. Eligible families will be randomized and offered a preventive intervention program in a group format, led by program facilitators in a community setting. The intervention program consists of 3 sessions plus an individualized family meeting. In some modules parents/guardians/caregivers and adolescents will have content delivered together and in some modules parents/guardians/caregivers and adolescents will break out to adult-only or adolescent-only groups.

The overall objective of study is to assess the following study questions:

Question 1: Is this study feasible? Question 2: Is this intervention acceptable to the target population? Question 3: Is there preliminary evidence of hypothesized effects of the intervention, that the intervention will reduce or maintaining symptoms that fall below the clinically significant range for depression and reduce or delay actual or intended sexual risk behavior in adolescents?

The study takes a single blind, randomized pilot trial. The study takes a secondary prevention approach. The investigators collect three sets of data. First, the investigators assess feasibility by examining recruitment rates, attendance, completion, and drop-out rates, and fidelity. Second, the investigators assess acceptability by examining satisfaction data. Third, as a secondary aim, the investigators use pilot data to assess hypothesized intervention effects by examining outcomes at baseline, immediately post-intervention (2-4 weeks after the last intervention session is completed), and at four months.


Recruitment information / eligibility

Status Completed
Enrollment 152
Est. completion date July 31, 2017
Est. primary completion date July 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

PARENTS/GUARDIANS/CAREGIVERS

1. 18+ years

2. primary caregiver or the person responsible for childcare in the household on a day to day basis (as identified by the household);

3. when more than one primary caregiver exists in the household, one will be chosen at random;

4. lives in the household at least 4 days a week

5. sub clinical thresholds of depressive symptoms

Adolescent inclusion criteria are:

1. 13-15 years;

2. concurs that the adult identified is their primary caregiver;

3. when more than one child in the family falls within the eligible age range, one child will be chosen at random;

4. lives in the household at least 4 days a week;

5. sub clinical thresholds of depressive symptoms

Exclusion Criteria:

PARENTS/GUARDIANS/CAREGIVERS & Adolescents

1. cognitive impairments that would not allow them to provide informed consent or assent;

2. if they participated in qualitative phases of the study

3. report no or low symptoms or clinically significant thresholds of depression -

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Our Family Our Future
The Our Family Our Future Program is a family preventive intervention that uses resilience and prevention focused strategies to reduce sexual risk behaviors and build mental wellbeing among adolescents.

Locations

Country Name City State
South Africa Caroline Kuo Cape Town Western Cape

Sponsors (2)

Lead Sponsor Collaborator
Brown University University of Cape Town

Country where clinical trial is conducted

South Africa, 

References & Publications (1)

Kuo C, Atujuna M, Mathews C, Stein DJ, Hoare J, Beardslee W, Operario D, Cluver L, K Brown L. Developing family interventions for adolescent HIV prevention in South Africa. AIDS Care. 2016;28 Suppl 1:106-10. doi: 10.1080/09540121.2016.1146396. Epub 2016 F — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in sexual behavior or intended sexual behavior at 4 months post-intervention as measured through lifetime and past 3 month sexual acts, condom use, HIV and STI status, prior pregnancy assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Primary Change or maintenance of depressive symptoms at sub-clinical range from baseline to 4 months post-intervention measured by CES-D and CES-DC Self-reported depressive symptoms assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Primary Intervention acceptability - satisfaction with intervention content, delivery, length using the client satisfaction questionnaire and as measured on a likert scale response and as open-ended response options acceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
Primary Intervention feasibility measured by attendance, retention for outcome assessments, fidelity cceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
Secondary Change in resilience from baseline to 4 months post-intervention as measured through CD-RISC assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in depression impairment from baseline to 4 months post-intervention as measured through DISP and CPODMV assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in perceived HIV risk susceptibility from baseline to 4 months post-intervention using a ranking derived from a 0-100 and as measured on a likert scale response assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in HIV knowledge from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in HIV stigma from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in norms and attitudes about sex from baseline to 4 months post-intervention as measured on a likert scale response assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in norms and attitudes about condoms from baseline to 4 months post-intervention as measured through the condom attitudes scale and likert response questions assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in sexual behavior self-efficacy from baseline to 4 months post-interventionusing a ranking derived from a 0-100 and as measured on a likert scale response assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in anxiety from baseline to 4 months post-interventionas measured through BAI and RCMAS assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in psychological distress from baseline to 4 months post-intervention as measured through K6 and SDQ assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in trauma symptoms from baseline to 4 months post-intervention as measured through PCL and NSESSS assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in substance use from baseline to 4 months post-intervention as measured through AUDIT and DUDIT assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in hope from baseline to 4 months post-intervention as measured through BHS assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in social support from baseline to 4 months post-intervention as measured through MSPSS assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in family relationship from baseline to 4 months post-intervention as measured through Family Relationship Scale assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Communication Scale assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Sex Communication Scale assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in family relationship from baseline to 4 months post-intervention as measured through the Inventory of Parent-peer Attachment assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in parenting from baseline to 4 months post-interventionas measured through the Parental Monitoring Questionnaire assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Secondary Change in parenting from baseline to 4 months post-intervention as measured through the Parenting Scale assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A